2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Nasdaq notified Skye Bioscience on August 18, 2026 that its stockholders' equity of ($497,307), as reported in its June 30, 2026 quarterly report, falls short of the $2,500,000 minimum under Nasdaq Capital Market Listing Rule 5550(b)(1). The notice has no immediate effect on the listing, and the stock continues to trade as SKYE, but the company must submit a plan to regain compliance and says there is no assurance it will do so. The notice comes alongside a pending acquisition of Redx Pharma Limited, which adds uncertainty for shareholders.
Stockholders' equity was ($497,307) versus a $2,500,000 minimum under Nasdaq Listing Rule 5550(b)(1)
Stock continues to trade on the Nasdaq Capital Market under SKYE; the notice has no immediate effect on listing
Compliance plan due October 2, 2026; if accepted, Nasdaq can grant an extension to February 14, 2027
Company is evaluating alternatives and says there can be no assurance it will regain compliance; Redx transaction agreement is dated August 14, 2026
Liminatus Pharma said it will carry out a 1-for-50 reverse stock split of its common stock, effective August 20, 2026, so its shares can meet Nasdaq's $1.00 minimum bid price. The company remains listed under a Nasdaq Panel exception, but it must show a $1.00 closing bid for at least ten consecutive trading days by September 3, 2026, and the company says it cannot assure it will do so.
Reverse split ratio of 1-for-50, with split-adjusted trading under LIMN on The Nasdaq Capital Market expected at the market open on August 21, 2026
New CUSIP number 53271X 207; fractional shares will be rounded up to the nearest whole share, with no cash paid for fractions
Based on July 2, 2026 figures, outstanding shares would fall from 67,160,362 to approximately 1,343,208
Nasdaq Panel extended the deadline to demonstrate compliance with Listing Rule 5550(a)(2) to September 3, 2026
Nasdaq notified ZW Data Action Technologies on August 17, 2026 that the company has regained compliance with the $1.00 minimum bid price rule. The closing bid price was at or above $1.00 for the 10 consecutive business days from August 3 to August 14, 2026, and the deficiency matter is now closed. The filing involves a compliance notice and no change to financial results, which removes a listing-standards issue flagged in March 2026.
Nasdaq letter dated August 17, 2026 confirmed regained compliance with Listing Rule 5550(a)(2)
Compliance rests on closing bid prices at or above $1.00 from August 3 to August 14, 2026
Nasdaq first flagged the company on March 26, 2026, for trading below $1 for 30 consecutive business days
The U.S. District Court for the Eastern District of New York granted final approval on August 14, 2026, to settle two shareholder derivative lawsuits against Virgin Galactic. The company said the settlement resolves all pending claims, with no finding of wrongdoing by the company or its directors or officers, which removes the litigation as an open matter for shareholders.
Court order dated August 14, 2026 grants final approval of the settlement of the In re Virgin Galactic Holdings, Inc. Derivative Litigation and St. Jean v. Branson derivative actions
Company's insurers will pay $2.75 million; Virgin Galactic will keep half, and the remaining half goes to plaintiffs' counsel for attorneys' fees and costs
All related claims are fully released, and the settlement involves no finding of wrongdoing by the company or any of its directors or officers
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.